AAAAAA

   
Results: 1-11 |
Results: 11
Human resource practices, organizational climate, and customer satisfaction
Authors: Rogg, KL Schmidt, DB Shull, C Schmitt, N
Citation: Kl. Rogg et al., Human resource practices, organizational climate, and customer satisfaction, J MANAG, 27(4), 2001, pp. 431-449
Molecular and pharmacological characterization of the murine tachykinin NK3 receptor
Authors: Sarau, HM Feild, JA Ames, RS Foley, JJ Nuthulaganti, P Schmidt, DB Buckley, PT Elshourbagy, NA Brawner, ME Luttmann, MA Giardina, GAM Hay, DWP
Citation: Hm. Sarau et al., Molecular and pharmacological characterization of the murine tachykinin NK3 receptor, EUR J PHARM, 413(2-3), 2001, pp. 143-150
Evidence that the proposed novel human "neurokinin-4" receptor is pharmacologically similar to the human neurokinin-3 receptor but is not of human origin
Authors: Sarau, HM Mooney, JL Schmidt, DB Foley, JJ Buckley, PT Giardina, GAM Wang, DY Lee, JA Hay, DWP
Citation: Hm. Sarau et al., Evidence that the proposed novel human "neurokinin-4" receptor is pharmacologically similar to the human neurokinin-3 receptor but is not of human origin, MOLEC PHARM, 58(3), 2000, pp. 552-559
Identification and molecular characterization of rat CXCR3: Receptor expression and interferon-inducible protein-10 binding are increased in focal stroke
Authors: Wang, XK Li, X Schmidt, DB Foley, JJ Barone, FC Ames, RS Sarau, HM
Citation: Xk. Wang et al., Identification and molecular characterization of rat CXCR3: Receptor expression and interferon-inducible protein-10 binding are increased in focal stroke, MOLEC PHARM, 57(6), 2000, pp. 1190-1198
Nonpeptide tachykinin receptor antagonists. II. Ppharmacological and pharmacokinetic profile of SB-222200, a central nervous system penetrant, potentand selective NK-3 receptor antagonist
Authors: Sarau, HM Griswold, DE Bush, B Potts, W Sandhu, P Lundberg, D Foley, JJ Schmidt, DB Webb, EF Martin, LD Legos, JJ Whitmore, RG Barone, FC Medhurst, AD Luttmann, MA Giardina, GAM Hay, DWP
Citation: Hm. Sarau et al., Nonpeptide tachykinin receptor antagonists. II. Ppharmacological and pharmacokinetic profile of SB-222200, a central nervous system penetrant, potentand selective NK-3 receptor antagonist, J PHARM EXP, 295(1), 2000, pp. 373-381
Identification of potent, selective non-peptide CC chemokine receptor-3 antagonist that inhibits eotaxin-, eotaxin-2-, and monocyte chemotactic protein-4-induced eosinophil migration
Authors: White, JR Lee, JM Dede, K Imburgia, CS Jurewicz, AJ Chan, G Fornwald, JA Dhanak, D Christmann, LT Darcy, MG Widdowson, KL Foley, JJ Schmidt, DB Sarau, HM
Citation: Jr. White et al., Identification of potent, selective non-peptide CC chemokine receptor-3 antagonist that inhibits eotaxin-, eotaxin-2-, and monocyte chemotactic protein-4-induced eosinophil migration, J BIOL CHEM, 275(47), 2000, pp. 36626-36631
Receptor for the pain modulatory neuropeptides FF and AF is an orphan G protein-coupled receptor
Authors: Elshourbagy, NA Ames, RS Fitzgerald, LR Foley, JJ Chambers, JK Szekeres, PG Evans, NA Schmidt, DB Buckley, PT Dytko, GM Murdock, PR Milligan, G Groarke, DA Tan, KB Shabon, U Nuthulaganti, P Wang, DY Wilson, S Bergsma, DJ Sarau, HM
Citation: Na. Elshourbagy et al., Receptor for the pain modulatory neuropeptides FF and AF is an orphan G protein-coupled receptor, J BIOL CHEM, 275(34), 2000, pp. 25965-25971
In vitro and in vivo pharmacological characterization of SB 201993, an eicosanoid-like LTB4 receptor antagonist with anti-inflammatory activity
Authors: Sarau, HM Foley, JJ Schmidt, DB Martin, LD Webb, EF Tzimas, MN Breton, JJ Chabot-Fletcher, M Underwood, DC Hay, DWP Kingsbury, WD Chambers, PA Pendrak, I Jakas, DR Sathe, GM Van Horn, S Daines, RA Griswold, DE
Citation: Hm. Sarau et al., In vitro and in vivo pharmacological characterization of SB 201993, an eicosanoid-like LTB4 receptor antagonist with anti-inflammatory activity, PROS LEUK E, 61(1), 1999, pp. 55-64
Identification, molecular cloning, expression, and characterization of a cysteinyl leukotriene receptor
Authors: Sarau, HM Ames, RS Chambers, J Ellis, C Elshourbagy, N Foley, JJ Schmidt, DB Muccitelli, RM Jenkins, O Murdock, PR Herrity, NC Halsey, W Sathe, G Muir, AI Nuthulaganti, P Dytko, GM Buckley, PT Wilson, S Bergsma, DJ Hay, DWP
Citation: Hm. Sarau et al., Identification, molecular cloning, expression, and characterization of a cysteinyl leukotriene receptor, MOLEC PHARM, 56(3), 1999, pp. 657-663
Discovery of a novel class of selective non-peptide antagonists for the human neurokinin-3 receptor. 2. Identification of (S)-N-(1-phenylpropyl)-3-hydroxy-2-phenylquinoline-4-carboxamide (SB 223412)
Authors: Giardina, GAM Raveglia, LF Grugni, M Sarau, HM Farina, C Medhurst, AD Graziani, D Schmidt, DB Rigolio, R Luttmann, M Cavagnera, S Foley, JJ Vecchietti, V Hay, DWP
Citation: Gam. Giardina et al., Discovery of a novel class of selective non-peptide antagonists for the human neurokinin-3 receptor. 2. Identification of (S)-N-(1-phenylpropyl)-3-hydroxy-2-phenylquinoline-4-carboxamide (SB 223412), J MED CHEM, 42(6), 1999, pp. 1053-1065
Replacement of the quinoline system in 2-phenyl-4-quinolinecarboxamide NK-3 receptor antagonists
Authors: Giardina, GAM Artico, M Cavagnera, S Cerri, A Consolandi, E Gagliardi, S Graziani, D Grugni, M Hay, DWP Luttmann, MA Mena, R Raveglia, LF Rigolio, R Sarau, HM Schmidt, DB Zanoni, G Farina, C
Citation: Gam. Giardina et al., Replacement of the quinoline system in 2-phenyl-4-quinolinecarboxamide NK-3 receptor antagonists, FARMACO, 54(6), 1999, pp. 364-374
Risultati: 1-11 |